Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine.
This study is ongoing, but not recruiting participants.
Study NCT00540449 Information provided by Tibotec Pharmaceuticals, Ireland
First Received: October 4, 2007 Last Updated: July 17, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
HIV Infections
HIV-1
Human Immunodeficiency Virus Type 1
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
Immunologic Deficiency Syndromes
Infection
More general conditions related to this trial
Immune System Diseases
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Virus Diseases
Interventions listed in this trial
TMC278
efavirenz
Additional drug interventions recognized in this trial
Emtricitabine
Reverse Transcriptase Inhibitors
Tenofovir disoproxil
More general drug interventions related to this trial
Anti-HIV Agents
Anti-Infective Agents
Anti-Retroviral Agents
Antiviral Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Tibotec Pharmaceuticals, Ireland
Back to top of Main Content
